Advanced Search

Neuro-Oncology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Wolfgang Grisold

    Wolfgang Grisold

    Neurologische Abteilung, Kaiser Franz Josef Spital, Wien, Austria

  • Photo of Jerome Posner

    Jerome Posner

    Department of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Section Topics

  • » Nervous system metastases: brain
  • » Nervous system metastases: leptomeningeal
  • » Nervous system metastases: peripheral nerves
  • » Nervous system metastases: spine
  • » Non-metastatic complications of cancer: infections
  • » Non-metastatic complications of cancer: metabolic - nutritional
  • » Non-metastatic complications of cancer: paraneoplastic syndrome
  • » Non-metastatic complications of cancer: side-effects of cancer therapies
  • » Non-metastatic complications of cancer: vascular
  • » Primary nervous system tumors: animal models
  • » Primary nervous system tumors: cell biology
  • » Primary nervous system tumors: diagnosis
  • » Primary nervous system tumors: genetics
  • » Primary nervous system tumors: immunology
  • » Supportive care of patients with nervous system tumors
  • » Therapy of primary nervous system tumors: RT
  • » Therapy of primary nervous system tumors: chemobiology
  • » Therapy of primary nervous system tumors: surgery

LATEST EVALUATION

What is the cell of origin of gliomas? This is one of the fundamental questions that we are not able to answer for students, patients or ourselves. Nevertheless, we would be at least one step...

Christine Marosi, Medical University of Vienna, Austria. F1000 Neurological Disorders

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Witt H, Mack SC, Ryzhova M, Bender S, ..., Lichter P, Korshunov A, Taylor MD, Pfister SM. Cancer Cell. 2011 Aug 16; 20(2):143-57

1 Evaluation, most recent by

Jan Stary and Michal Zapotocky, University Hospital Motol, Czech Republic. F1000 Hematology

  • New Finding
  • Novel Drug Target

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000